Ordeniza, Elisa C.

HRN: 17-13-72  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/28/2024
CEFTAZIDIME 1GM (VIAL)
12/28/2024
01/04/2025
IV
1g
Every 8 Hours
DM Foot
Waiting Final Action 
12/28/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
12/28/2024
01/04/2025
IV
600mg
Every 8 Hours
DM Foot
Waiting Final Action 
01/01/2025
CEFTAZIDIME 1GM (VIAL)
01/01/2025
01/08/2025
IVTT
2g
Q8
DM FOOT
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: